Skip to main content

Find Clinical Trials

Home
Conditions
Hamartoma

Clinical trial condition

Hamartoma

Explore clinical trials studying Hamartoma. Study availability and eligibility vary by location and protocol.

108 public trials 27 recruiting studies

Refine in advanced search Browse all conditions

Hamartoma trial results

Completed

Informed Consent for Whole Genome Sequencing: Ideals and Norms Referenced by Early Participants

NCT01369953

Conditions: Abnormalities, Multiple, Arterial Occlusive Diseases, Arteriosclerosis, +23 more
Locations: National Human Genome Research Institute (NHGRI), 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Trial of RAD001 and Neurocognition in Tuberous Sclerosis Complex (TSC)

NCT01289912

Conditions: Autism Spectrum Disorder, Autistic Disorder, Child Development Disorders, Pervasive, +18 more
Locations: Boston Children's Hospital Boston, Massachusetts, United States

Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States

View Trial Details

Completed

Topical Rapamycin and Calcitriol for Angiofibroma of Tuberous Sclerosis

NCT03140449

Conditions: Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Facial Angiofibroma, +13 more
Locations: Not specified

View Trial Details

Completed

Tuberous Sclerosis Complex Natural History Study: Renal Manifestations

NCT00598455

Conditions: Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +13 more
Locations: Cincinnati Children's Cincinnati, Ohio, United States

View Trial Details

Completed

Everolimus (RAD001) Therapy for Epilepsy in Patients With Tuberous Sclerosis Complex (TSC)

NCT01070316

Conditions: Brain Diseases, Central Nervous System Diseases, Congenital Abnormalities, +20 more
Locations: Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States

Baylor College of Medicine Houston, Texas, United States

View Trial Details

Completed

Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM)

NCT00790400

Conditions: Angiomyolipoma, Astrocytoma, Congenital Abnormalities, +43 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

Barrow Tuberous Sclerosis Center Phoenix, Arizona, United States

Massachusetts General Hospital Massachussetts General Hospita Boston, Massachusetts, United States

Minnesota Epilepsy Group Saint Paul, Minnesota, United States

View all 25 locations

View Trial Details

Completed

Phase III Trial of Topical Formulation of Sirolimus to Skin Lesions in Patients With Tuberous Sclerosis Complex (TSC)

NCT02635789

Conditions: Angiofibroma, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +20 more
Locations: Graduate School of Medicine, Osaka University Suita, Osaka, Japan

View Trial Details

Completed

Tuberous Sclerosis Complex: Facial Angiofibroma Skin Cream

NCT01853423

Conditions: Angiofibroma, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +16 more
Locations: LeBonheur Children's Hospital Memphis, Tennessee, United States

View Trial Details

Completed

Efficacy and Safety of Everolimus (RAD001) in Patients of All Ages With Subependymal Giant Cell Astrocytoma Associated With Tuberous Sclerosis Complex (TSC)(EXIST-1)

NCT00789828

Conditions: Astrocytoma, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +21 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

Barrow Tuberous Sclerosis Center Phoenix, Arizona, United States

University of California at Los Angeles Los Angeles, California, United States

Children's Hospital Oakland Hematology/Oncology Dept Oakland, California, United States

View all 24 locations

View Trial Details

Completed

Doxycycline In Lymphangioleiomyomatosis (LAM)

NCT00989742

Conditions: Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +23 more
Locations: Nottingham University Hospitals Nottingham, United Kingdom

View Trial Details